Pharma & Life Sciences

BIO-Europe Fall 2026

BIO-Europe Fall 2026 is a global life science partnering event for the biopharma C-suite, investors, and partners. It includes a comprehensive program covering partnering, investment, regulatory developments, clinical affairs, and manufacturing strategy.

Official websiteRegisterAgenda
8 weeks until it opens.

The essentials

Event details

Dates
9 November 2026 to 11 November 2026
Location
Koelnmesse, Cologne, Germany
Organiser
Informa Connect
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • Design
  • Technology
  • Manufacturing
  • Health
  • Legal
  • Leadership
  • Research
  • Biotech
  • Evolution
  • Pharma
  • Future
  • Innovation

On stage

Speakers

  • Jeremy LevinExecutive Chairman, Ovid Therapeutics Inc
  • Jessica FedererManaging Director, Angelini Ventures
  • Anja HarmeierHead of Roche Venture Fund, Roche Ventures
  • Steve YangCo-CEO, WuXi AppTec

Logistics

Where to stay

Places to stay near the venue.

Stay on it

Get the next edition

When BIO-Europe Fall 2026 announces its next edition, or these dates change, we read it from the organiser's own site. One email when that happens, nothing else.

One email per announcement. Unsubscribe in a click, and we never pass your address on.

Plan this event

Work out who to meet here

Luminik sources the attendee picture for an event like BIO-Europe Fall 2026, enriches it against your ICP, and sequences it ahead of the date. Capture at the event writes to Salesforce or HubSpot the same day, and attribution ties the pipeline back to the spend.

Book a 20-min walkthrough

Spot something wrong on this page? Report a correction and we will fix it.

Is this your event? Verify it with your work email: one click in your inbox proves it is yours, we approve, and the badge goes up, usually within a day. Prefer the form?

If your email matches the event's own domain, one click in your inbox completes your side; we approve and the badge goes up, usually within a day. Otherwise we check by hand, same as always.